356 related articles for article (PubMed ID: 1609408)
1. Renal cadmium deposition and injury as a result of accumulation of cadmium-metallothionein (CdMT) by the proximal convoluted tubules--A light microscopic autoradiography study with 109CdMT.
Dorian C; Gattone VH; Klaasen CD
Toxicol Appl Pharmacol; 1992 Jun; 114(2):173-81. PubMed ID: 1609408
[TBL] [Abstract][Full Text] [Related]
2. Accumulation and degradation of the protein moiety of cadmium-metallothionein (CdMT) in the mouse kidney.
Dorian C; Gattone VH; Klaassen CD
Toxicol Appl Pharmacol; 1992 Dec; 117(2):242-8. PubMed ID: 1471157
[TBL] [Abstract][Full Text] [Related]
3. Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules.
Dorian C; Gattone VH; Klaassen CD
Toxicol Appl Pharmacol; 1995 Jan; 130(1):161-8. PubMed ID: 7839364
[TBL] [Abstract][Full Text] [Related]
4. Nephrotoxicity of CdCl2 and Cd-metallothionein in cultured rat kidney proximal tubules and LLC-PK1 cells.
Liu J; Liu Y; Klaassen CD
Toxicol Appl Pharmacol; 1994 Oct; 128(2):264-70. PubMed ID: 7940541
[TBL] [Abstract][Full Text] [Related]
5. Protection by zinc-metallothionein (ZnMT) against cadmium-metallothionein-induced nephrotoxicity.
Dorian C; Klaassen CD
Fundam Appl Toxicol; 1995 Jun; 26(1):99-106. PubMed ID: 7657068
[TBL] [Abstract][Full Text] [Related]
6. Cadmium-metallothionein-induced nephropathy: a morphological and autoradiographic study of cadmium distribution, the development of tubular damage and subsequent cell regeneration.
Murakami M; Cain K; Webb M
J Appl Toxicol; 1983 Oct; 3(5):237-44. PubMed ID: 6662997
[TBL] [Abstract][Full Text] [Related]
7. Kidney synthesizes less metallothionein than liver in response to cadmium chloride and cadmium-metallothionein.
Sendelbach LE; Klaassen CD
Toxicol Appl Pharmacol; 1988 Jan; 92(1):95-102. PubMed ID: 3341030
[TBL] [Abstract][Full Text] [Related]
8. Distribution of cadmium chloride and cadmium-metallothionein to liver parenchymal, Kupffer, and endothelial cells: their relative ability to express metallothionein.
McKim JM; Liu J; Liu YP; Klaassen CD
Toxicol Appl Pharmacol; 1992 Feb; 112(2):324-30. PubMed ID: 1539169
[TBL] [Abstract][Full Text] [Related]
9. Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.
Liu J; Habeebu SS; Liu Y; Klaassen CD
Toxicol Appl Pharmacol; 1998 Nov; 153(1):48-58. PubMed ID: 9875299
[TBL] [Abstract][Full Text] [Related]
10. Dietary iron lowers the intestinal uptake of cadmium-metallothionein in rats.
Groten JP; Luten JB; van Bladeren PJ
Eur J Pharmacol; 1992 May; 228(1):23-8. PubMed ID: 1397065
[TBL] [Abstract][Full Text] [Related]
11. Renal accumulation of cadmium and nephropathy following long-term administration of cadmium-metallothionein.
Min KS; Onosaka S; Tanaka K
Toxicol Appl Pharmacol; 1996 Nov; 141(1):102-9. PubMed ID: 8917681
[TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity of cadmium-metallothionein: protection by zinc and role of glutathione.
Tang W; Sadovic S; Shaikh ZA
Toxicol Appl Pharmacol; 1998 Aug; 151(2):276-82. PubMed ID: 9707504
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein protects against the nephrotoxicity produced by chronic CdMT exposure.
Liu Y; Liu J; Habeebu SS; Klaassen CD
Toxicol Sci; 1999 Aug; 50(2):221-7. PubMed ID: 10478858
[TBL] [Abstract][Full Text] [Related]
14. Cadmium accumulation and metallothionein concentrations after 4-week dietary exposure to cadmium chloride or cadmium-metallothionein in rats.
Groten JP; Sinkeldam EJ; Luten JB; van Bladeren PJ
Toxicol Appl Pharmacol; 1991 Dec; 111(3):504-13. PubMed ID: 1746026
[TBL] [Abstract][Full Text] [Related]
15. Influence of cadmium-metallothionein pretreatment on tolerance of rat kidney cortical cells to cadmium toxicity in vitro and in vivo.
Jin T; Nordberg GF; Nordberg M
Pharmacol Toxicol; 1987 May; 60(5):345-9. PubMed ID: 3615344
[TBL] [Abstract][Full Text] [Related]
16. Increased Endocytosis of Cadmium-Metallothionein through the 24p3 Receptor in an In Vivo Model with Reduced Proximal Tubular Activity.
Zavala-Guevara IP; Ortega-Romero MS; Narváez-Morales J; Jacobo-Estrada TL; Lee WK; Arreola-Mendoza L; Thévenod F; Barbier OC
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298880
[TBL] [Abstract][Full Text] [Related]
17. Cadmium-Metallothionein nephropathy: relationships between ultrastructural/biochemical alterations and intracellular cadmium binding.
Squibb KS; Pritchard JB; Fowler BA
J Pharmacol Exp Ther; 1984 Apr; 229(1):311-21. PubMed ID: 6707945
[TBL] [Abstract][Full Text] [Related]
18. Subcellular targets of cadmium nephrotoxicity: cadmium binding to renal membrane proteins in animals with or without protective metallothionein synthesis.
Nordberg GF; Jin T; Nordberg M
Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):191-4. PubMed ID: 7843096
[TBL] [Abstract][Full Text] [Related]
19. Comparison of renal toxicity after long-term oral administration of cadmium chloride and cadmium-metallothionein in rats.
Groten JP; Koeman JH; van Nesselrooij JH; Luten JB; Fentener van Vlissingen JM; Stenhuis WS; van Bladeren PJ
Fundam Appl Toxicol; 1994 Nov; 23(4):544-52. PubMed ID: 7867906
[TBL] [Abstract][Full Text] [Related]
20. Fate of cadmium in rat renal tubules: a microinjection study.
Felley-Bosco E; Diezi J
Toxicol Appl Pharmacol; 1987 Nov; 91(2):204-11. PubMed ID: 3672521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
